Inactive Instrument

Insiders Catalyst Biosciences Inc Nasdaq

Equities

US14888D1090

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index	CI
2023	Beijing Continent Pharmaceutical Co., Ltd. completed the acquisition of Catalyst Biosciences, Inc. in a reverse merger transaction.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Catalyst Biosciences, Inc. has Changed its Name to Gyre Therapeutics, Inc	23-08-29	CI
Catalyst Biosciences, Inc. Terminates Grant Blouse from the Position as the Chief Scientific Officer	23-01-19	CI
Aeglea BioTherapeutics Promotes Linda Neuman to Chief Medical Officer	22-11-16	MT
JDS1 Announces Withdrawal of Nominations at Catalyst Biosciences	22-08-03	CI
Julian D. Singer Nominates Candidates to the Board of Catalyst Biosciences	22-03-07	CI
Catalyst Biosciences : CFO Resigns; Interim Successor Named	21-10-13	MT
Catalyst Biosciences, Inc. Announces Promotion of Seline Miller to Senior Vice President, Finance and Will Serve as Principal Accounting Officer	21-10-13	CI
Catalyst Biosciences, Inc. Appoints Jeanne Jew to Board of Directors	21-09-08	CI
Catalyst Biosciences, Inc. Announces the Retirement of Howard Levy as its Chief Medical Officer	21-08-16	CI
Catalyst Biosciences, Inc. Announces Executive Changes	21-07-14	CI
Catalyst Biosciences, Inc. Appoints Charles Democko as Senior Vice President, Regulatory Affairs	20-06-22	CI
Catalyst Biosciences Appoints Clinton Musil as Chief Financial Officer, Effective July 1, 2020	20-06-15	CI
Veronica Cai to Resign as Principal Accounting Officer and Controller of Catalyst Biosciences, Inc, Effective April 15, 2020	20-03-20	CI
Catalyst Biosciences, Inc. Announces Board Changes	20-01-17	CI
Catalyst Biosciences, Inc. Appoints Grant Blouse as Vice President of Translational Research	18-07-10	CI
Catalyst Biosciences, Inc. Announces Management Changes	17-12-14	CI
Catalyst Biosciences, Inc. Announces Executive Appointments	17-11-28	CI
Catalyst Biosciences, Inc. Appoints Andrea Hunt to its Board of Directors	17-10-26	CI
Catalyst Biosciences, Inc. Promotes Andrew Hetherington to Senior Vice President of Technical Operations	17-02-16	CI
Catalyst Biosciences, Inc. Announces Termination of Edwin Madison as Chief Scientific Officer	16-09-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Catalyst Biosciences Inc Nasdaq

Equities

US14888D1090

Insiders

Filters